Company: PHR
Filing Date: 2025-12-09
Form Type: 10-Q
Source: 0001412408-25-000132
Chunk: 287

Company: Phreesia, Inc.
Filing Date: 2025-12-09
Form: 10-Q
Item: Part I, Item 2
Chunk 287
---
 31, 2025, as compared to $49.7 million for the nine months ended October 31, 2024. The increase resulted primarily from a $8.1 million increase in other third-party costs, partially offset by a $5.4 million decrease in labor costs.

Stock compensation incurred related to cost of revenue was $3.0 million and $3.7 million for the nine months ended October 31, 2025 and 2024, respectively.

Payment processing expense Three months endedOctober 31, ($ in thousands)20252024$ Change% ChangePayment processing expense$19,689 $16,683 $3,006 18 %

Payment processing expense increased $3.0 million to $19.7 million for the three months ended October 31, 2025, as compared to $16.7 million for the three months ended October 31, 2024. The increase resulted primarily from the increase in payment processing fees revenue and patient payments processed through our solutions, each driven by an increase in patient visits over the prior year.

 Nine months endedOctober 31, ($ in thousands)20252024$ Change% ChangePayment processing expense$61,360 $51,648 $9,712 19 %

Payment processing expense increased $9.7 million to $61.4 million for the nine months ended October 31, 2025, as compared to $51.6 million for the nine months ended October 31, 2024. The increase resulted primarily from the increase in payment processing fees revenue and patient payments processed through our solutions, each driven by an increase in patient visits over the prior year.

Sales and marketing Three months endedOctober 31, ($ in thousands)20252024$ Change% ChangeSales and marketing$24,148 $30,071 $(5,923)(20)%

Sales and marketing expense decreased $5.9 million to $24.1 million for the three months ended October 31, 2025, as compared to $30.1 million for the three months ended October 31, 2024. The decrease resulted primarily from a $7.3 million decrease in labor costs, partially offset by a $1.3 million increase in other third-party sales and marketing costs.

44

Stock compensation incurred related to sales and marketing expense was $4.8 million and $5.4 million for the three months ended October